Auxilium Pharmaceuticals (AUXL) gains on Endo deal

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) shares hiked 0.7% to $32.92, after the company and Endo International announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act") in connection with Endo's proposed acquisition of Auxilium was terminated by the United States Federal Trade Commission on November 18. Share volume was 154,000, compared to an all-day average of 2.2 million